Our findings clearly lend support to the use of GLP-1 agonists in combination with basal insulin in the clinical management of patients with type 2 diabetes. Victoria Ruszala, a diabetes pharmacist at North Bristol NHS Trust, said that the study provided reassurance about the co-prescription of GLP-1 agonists and basal insulin, already widely practised and endorsed by expert bodies such as the Association of British Clinical Diabetologists
So, whats this craze about and what should you know before taking or injecting peptides
This meant subcutaneous injections of unmodified GLP-1 would not sustain therapeutic levels
Retatrutide trials have explored various dosing strategies, with optimal dosing still being determined through ongoing research
So before you get started with peptides, you need to understand what these terms mean, so you can start researching what they do and the possible effects on your body
10.1016/0167-4943(95)00690-7 Salehi B, Berkay Ylmaz Y, Antika G, et al.: Insights on the Use of -Lipoic Acid for Therapeutic Purposes